Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Jianlong Bioengineering is a prominent Chinese biotechnology firm focused on the industrial-scale production of amino acids via microbial fermentation. As a key subsidiary of the Jianlong Group, the company has established itself as one of the world's largest producers of feed-grade L-tryptophan. Their operations integrate advanced bio-manufacturing technologies to supply the global animal nutrition and food additive industries. Beyond tryptophan, the company produces other high-value amino acids and bio-based chemicals. Jilin Jianlong Bioengineering maintains large-scale manufacturing facilities in Jilin Province, adhering to international quality standards for global export.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Jianlong Bioengineering.